Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.

Reporting results of cancer treatment

1981 • 7,916 citations

Binomial Confidence Intervals

1983 • 395 citations

New folate analogs of the 10-deaza-aminopterin series Basis for structural design and biochemical and pharmacologic properties

1984 • 143 citations

New folate analogs of the 10-deaza-aminopterin series

1984 • 138 citations

Evaluation of response criteria in advanced lung cancer

1979 • 105 citations

Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment

1985 • 77 citations

New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.

1985 • 69 citations

Methotrexate compared with placebo in lung cancer

1977 • 28 citations

Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.

1982 • 21 citations

Phase II study of high-dose methotrexate in the treatment of patients with non-small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.

1980 • 11 citations

Oral high-dose methotrexate with citrovorum factor rescue in metastatic squamous cell carcinoma of the lung

1978 • 8 citations

Phase I trial and clinical pharmacologic study of 10-ethyl-10-deaza-aminopterin (10-EdAM)

1985 • 6 citations